CASE: The objective of this case report is to report the development of tardive dyskinesia in an African-American adolescent male after short-term treatment with metoclopramide 10 mg orally three times daily secondary to delayed gastric emptying. The patient developed symptoms of tardive dyskinesia after 2 days of therapy with metoclopramide. Metoclopramide was discontinued and diphenhydramine 50 mg was initially administered intravenously followed with 25 mg orally every 4 hours as needed. While there are case reports of drug-induced tardive dyskinesia after intravenous administration of metoclopramide, this is to our knowledge the first report of tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent. CONCLUSION: Awareness of the risk of development of this adverse effect even with short-term treatment with metoclopramide and in younger patients is important.
CASE: The objective of this case report is to report the development of tardive dyskinesia in an African-American adolescent male after short-term treatment with metoclopramide 10 mg orally three times daily secondary to delayed gastric emptying. The patient developed symptoms of tardive dyskinesia after 2 days of therapy with metoclopramide. Metoclopramide was discontinued and diphenhydramine 50 mg was initially administered intravenously followed with 25 mg orally every 4 hours as needed. While there are case reports of drug-induced tardive dyskinesia after intravenous administration of metoclopramide, this is to our knowledge the first report of tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent. CONCLUSION: Awareness of the risk of development of this adverse effect even with short-term treatment with metoclopramide and in younger patients is important.
Authors: Stephen R Marder; Susan M Essock; Alexander L Miller; Robert W Buchanan; John M Davis; John M Kane; Jeffrey Lieberman; Nina R Schooler Journal: Schizophr Bull Date: 2002 Impact factor: 9.306
Authors: C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt Journal: Clin Pharmacol Ther Date: 1981-08 Impact factor: 6.875
Authors: G Gardos; D E Casey; J O Cole; A Perenyi; E Kocsis; M Arato; J A Samson; C Conley Journal: Am J Psychiatry Date: 1994-06 Impact factor: 18.112
Authors: Jing Qin Wu; Da Chun Chen; Yun Long Tan; Shu Ping Tan; Li Hui; Men Han Lv; Jair C Soares; Xiang Yang Zhang Journal: Psychopharmacology (Berl) Date: 2014-07-04 Impact factor: 4.530
Authors: Rachel S Meyers; Jennifer Thackray; Kelly L Matson; Christopher McPherson; Lisa Lubsch; Robert C Hellinga; David S Hoff Journal: J Pediatr Pharmacol Ther Date: 2020